RIGEL PHARMACEUTICALS, INC. (RIGL) Operating cash flow 2016–2025
RIGEL PHARMACEUTICALS, INC. (RIGL) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$75.7MFY2025 · since FY2016: -$75.9M → $75.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $75.7M | +140.4% |
| FY2024 | $31.5M | +648.0% |
| FY2023 | -$5.7M | +92.2% |
| FY2022 | -$73.8M | -1354.8% |
| FY2021 | $5.9M | +111.3% |
| FY2020 | -$52.2M | -25.7% |
| FY2019 | -$41.5M | +29.4% |
| FY2018 | -$58.8M | +24.2% |
| FY2017 | -$77.6M | -2.2% |
| FY2016 | -$75.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice